Literature DB >> 19836893

Four p67 alleles identified in South African Theileria parva field samples.

Kgomotso P Sibeko1, Dirk Geysen, Marinda C Oosthuizen, Conrad A Matthee, Milana Troskie, Frederick T Potgieter, Jacobus A W Coetzer, Nicola E Collins.   

Abstract

Previous studies characterizing the Theileria parva p67 gene in East Africa revealed two alleles. Cattle-derived isolates associated with East Coast fever (ECF) have a 129bp deletion in the central region of the p67 gene (allele 1), compared to buffalo-derived isolates with no deletion (allele 2). In South Africa, Corridor disease outbreaks occur if there is contact between infected buffalo and susceptible cattle in the presence of vector ticks. Although ECF was introduced into South Africa in the early 20th century, it has been eradicated and it is thought that there has been no cattle to cattle transmission of T. parva since. The variable region of the p67 gene was amplified and the gene sequences analyzed to characterize South African T. parva parasites that occur in buffalo, in cattle from farms where Corridor disease outbreaks were diagnosed and in experimentally infected cattle. Four p67 alleles were identified, including alleles 1 and 2 previously detected in East African cattle and buffalo, respectively, as well as two novel alleles, one with a different 174bp deletion (allele 3), the other with a similar sequence to allele 3 but with no deletion (allele 4). Sequence variants of allele 1 were obtained from field samples originating from both cattle and buffalo. Allele 1 was also obtained from a bovine that tested T. parva positive from a farm near Ladysmith in the KwaZulu-Natal Province. East Coast fever was not diagnosed on this farm, but the p67 sequence was identical to that of T. parva Muguga, an isolate that causes ECF in Kenya. Variants of allele 2 were obtained from all T. parva samples from both buffalo and cattle, except Lad 10 and Zam 5. Phylogenetic analysis revealed that alleles 3 and 4 are monophyletic and diverged early from the other alleles. These novel alleles were not identified from South African field samples collected from cattle; however allele 3, with a p67 sequence identical to those obtained in South African field samples from buffalo, was obtained from a Zambian field isolate of a naturally infected bovine diagnosed with ECF. The p67 genetic profiles appear to be more complex than previously thought and cannot be used to distinguish between cattle- and buffalo-derived T. parva isolates in South Africa. The significance of the different p67 alleles, particularly the novel variants, in the epidemiology of theileriosis in South Africa still needs to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836893     DOI: 10.1016/j.vetpar.2009.09.026

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  11 in total

1.  Construction of a genetic map for Theileria parva: identification of hotspots of recombination.

Authors:  Frank Katzer; Regina Lizundia; Daniel Ngugi; Damer Blake; Declan McKeever
Journal:  Int J Parasitol       Date:  2011-02-23       Impact factor: 3.981

2.  Molecular evolution of a central region containing B cell epitopes in the gene encoding the p67 sporozoite antigen within a field population of Theileria parva.

Authors:  Isaiah Obara; Seitzer Ulrike; Tony Musoke; Paul R Spooner; Ahmed Jabbar; David Odongo; Stephen Kemp; Joana C Silva; Richard P Bishop
Journal:  Parasitol Res       Date:  2015-02-13       Impact factor: 2.289

3.  Exposure of vaccinated and naive cattle to natural challenge from buffalo-derived Theileria parva.

Authors:  Tatjana Sitt; E Jane Poole; Gideon Ndambuki; Stephen Mwaura; Thomas Njoroge; George P Omondi; Matthew Mutinda; Joseph Mathenge; Giles Prettejohn; W Ivan Morrison; Philip Toye
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-05-08       Impact factor: 2.674

Review 4.  A review of Theileria diagnostics and epidemiology.

Authors:  Ben J Mans; Ronel Pienaar; Abdalla A Latif
Journal:  Int J Parasitol Parasites Wildl       Date:  2015-01-06       Impact factor: 2.674

Review 5.  Approaches to vaccination against Theileria parva and Theileria annulata.

Authors:  V Nene; W I Morrison
Journal:  Parasite Immunol       Date:  2016-12       Impact factor: 2.280

6.  Immune parameters to p67C antigen adjuvanted with ISA206VG correlate with protection against East Coast fever.

Authors:  Anna Lacasta; Stephen Mwalimu; Elisabeth Kibwana; Rosemary Saya; Elias Awino; Thomas Njoroge; Jane Poole; Nicholas Ndiwa; Roger Pelle; Vishvanath Nene; Lucilla Steinaa
Journal:  Vaccine       Date:  2018-03-07       Impact factor: 3.641

7.  Genetic Diversity and Sequence Polymorphism of Two Genes Encoding Theileria parva Antigens Recognized by CD8+ T Cells among Vaccinated and Unvaccinated Cattle in Malawi.

Authors:  Elisha Chatanga; Kyoko Hayashida; Walter Muleya; Kodai Kusakisako; Mohamed Abdallah Mohamed Moustafa; Bashir Salim; Ken Katakura; Chihiro Sugimoto; Nariaki Nonaka; Ryo Nakao
Journal:  Pathogens       Date:  2020-04-30

Review 8.  Theileria parva: a parasite of African buffalo, which has adapted to infect and undergo transmission in cattle.

Authors:  W Ivan Morrison; Johanneke D Hemmink; Philip G Toye
Journal:  Int J Parasitol       Date:  2020-02-04       Impact factor: 3.981

9.  Analysis of p67 allelic sequences reveals a subtype of allele type 1 unique to buffalo-derived Theileria parva parasites from southern Africa.

Authors:  Lubembe D Mukolwe; David O Odongo; Charles Byaruhanga; Louwtjie P Snyman; Kgomotso P Sibeko-Matjila
Journal:  PLoS One       Date:  2020-06-29       Impact factor: 3.240

10.  Variant analysis of the sporozoite surface antigen gene reveals that asymptomatic cattle from wildlife-livestock interface areas in northern Tanzania harbour buffalo-derived T. parva.

Authors:  Micky M Mwamuye; David Odongo; Yvette Kazungu; Fatuma Kindoro; Paul Gwakisa; Richard P Bishop; Ard M Nijhof; Isaiah Obara
Journal:  Parasitol Res       Date:  2020-10-03       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.